SGC001

DRUG2 trials

Sponsors

Beijing Sungen Biomedical Technology Co., Ltd

Conditions

Anterior Myocardial Infarction

Phase 1

A Research Study to Evaluate the Safety and Tolerability of SGC001 in Healthy Subjects

CompletedNCT07079618

Beijing Sungen Biomedical Technology Co., LtdAnterior Myocardial Infarction

Start: 2024-08-20End: 2025-07-15Updated: 2025-11-25

A Research Study to Evaluate the Safety and Preliminary Efficacy of SGC001 in Patients With Myocardial Infarction

CompletedNCT07091929

Beijing Sungen Biomedical Technology Co., LtdAnterior Myocardial Infarction

Start: 2025-01-20End: 2025-07-18Updated: 2026-01-12